NCT07039552View on ClinicalTrials.gov

Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2035

Conditions
Hereditary Breast and Ovarian Cancer SyndromeBRCA Mutations
Interventions
PROCEDURE

risk-reducing salpingo-oophorectomy (RRSO)

The proportion of BRCA1/2 germline mutation carriers in the high-risk population of ovarian cancer who undergo risk-reducing salpingo-oophorectomy (RRSO). RRSO refers to the preventive surgical removal of both fallopian tubes and ovaries to reduce the risk of ovarian cancer, fallopian tube cancer, and peritoneal cancer.

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER